Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format.
Stable producer cell lines helped to make mAb therapies the powerhouses that they are today. To deliver on the promise of AAV-based gene therapy for prevalent diseases, similar technology is required. The challenge is that multiple genetic elements – rep, helper, capsid, and gene of interest (GOI) – must be present. Ideally, everything needed to produce the required rAAV would be stably integrated into a single cell line.
In this webinar, we describe an all-inclusive cell line platform that can be customized for your specific GOI and capsid. Just add the induction agent, and you’re ready to go.